advertisement
We appreciate the very positive comments on the strength of the methods and findings of our recent papers from the Barbados Eye Studies (BESs) and the Early Manifest Glaucoma Trial (EMGT). Additional remarks follow regarding our results and their interpretation.
Despite the dissimilarities, the results of both analyses were remarkably consistent
Although both studies included a long follow-up period, they were markedly different in design and composition. Thus, our latest BESs results were based on a large national sample (n = 3222) of a popu-lation of African origin, while the EMGT was a randomized clinical trial conducted among Scandinavian glaucoma patients (n = 255). Their goals also differed, as the BESs analyses aimed to detect risk factors for newly developing, incident open-angle glaucoma, while the EMGT analyses aimed to identifyprogression factors for existing glaucoma. Yet despite these dissimilarities, the results of both analyses were remarkably consistent. In addition to the well-known relationships with age and intraocular pressure, the two studies suggested a role for low ocular perfusion pressure, low blood pressure and thinner central corneal thickness, both as risk factors for glaucoma incidence and as progression factors for established disease. These similarities support the possibility of relevant relationships, particularly since all the BESs participants, and most of the EMG patients, were identified from population-based samples.
Our new results strongly support a multifactorial causality in open-angle glaucoma, which is influenced by the interaction of genetic and non-genetic factors
Our data adds to prior evidence indicating that the associations of open-angle glaucoma to vascular factors are consistent, strong, and biologically plausible. However, both our papers extensively address the caveats in interpreting the findings, which are echoed by our colleagues. For example, a low ocular perfusion pressure could reflect the influence of low blood pressure, high intraocular pressure, treatment to lower blood pressure or intraocular pressure, or some combination. Our analyses attempted to carefully evaluate these issues and controlled for these and other pertinent variables.
The evidence for a role of vascular factors in glaucoma is mounting and is supported further by our new results.Furthermore, we did conduct analyses according to blood pressure status and systemic antihypertensive treatment, with generally similar and consistent patterns. Of course, these results must be followed up in future studies that focus on vascular factors, perhaps pooling data to increase numbers in subcategories. Similarly, the relation-ships with central corneal thickness await further clarification. As mentioned by our colleagues, the BESs provide the first such as-sociation found in a population-based study, lending further credence to the relationship.